{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:10Z","timestamp":1761630490909,"version":"3.35.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1992,6,1]],"date-time":"1992-06-01T00:00:00Z","timestamp":707356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1992,6,1]],"date-time":"1992-06-01T00:00:00Z","timestamp":707356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1992,6]]},"DOI":"10.1136\/ard.51.6.781","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"781-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Soluble interleukin 2 receptors in patients with polymyositis\/dermatomyositis."],"prefix":"10.1016","volume":"51","author":[{"given":"Y","family":"Tokano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.141.8.2612","article-title":"Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-I and IL-2 inhibition","volume":"141","author":"A, Symons J.; C, Wood N.; S, Di Giovine F.; W, Duff G.","year":"1988","unstructured":"Symons J A, Wood N C, Di Giovine F S, Duff G W. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-I and IL-2 inhibition. J Immunol 1988; 141: 2612-8.","journal-title":"J Immunol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/art.1780310704","article-title":"soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis","volume":"31","author":"C, Keystone E.","year":"1988","unstructured":"Keystone E C, Snow K M, Bombardier C, Chang C H, Nelson D L, Rubin L A. Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum 1988; 31: 844-9.","journal-title":"Arthritis Rheum"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/art.1780311103","article-title":"Serum levels of interleukin-2 receptor and activity of rheumatic disease characterized by immune system activation","volume":"31","author":"H, Campen D.; A, Horwitz D.; P, Quismorio F.; R, Ehresmann G.; J, Martin W.","year":"1988","unstructured":"Campen D H, Horwitz D A, Quismorio F P, Ehresmann G R, Martin W J. Serum levels of interleukin-2 receptor and activity of rheumatic disease characterized by immune system activation. Arthritis Rheum 1988; 31: 1358-64.","journal-title":"Arthritis Rheum"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0896-8411(88)90005-4","article-title":"Serum interleukin-2receptor in rheumatoid arthritis: a prognostic indicator of disease activity?","volume":"1","author":"C, Wood N.; A, Symons J.; W, Duff G.","year":"1988","unstructured":"Wood N C, Symons J A, Duff G W. Serum interleukin-2receptor in rheumatoid arthritis: a prognostic indicator of disease activity? J Autoimmun 1988; 1: 353-61.","journal-title":"J Autoimmun"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780310605","article-title":"Soluble interleukin-2 receptors in systemic lupus erythematosus","volume":"31","author":"E, Wolf R.; G, Brelsford W.","year":"1988","unstructured":"Wolf R E, Brelsford W G. Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 1988; 31: 729-35.","journal-title":"Arthritis Rheum"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/ard.48.10.803","article-title":"Relation between soluble interleukin-2 receptor and clinical findings in patients with systemic lupus erythematosus","volume":"48","author":"Tokano, Y.; Murashima, A.; Takasaki, Y.; Hashimoto, H.; Okumura, K.; Hirose, S.","year":"1989","unstructured":"Tokano Y, Murashima A, Takasaki Y, Hashimoto H, Okumura K, Hirose S. Relation between soluble interleukin-2 receptor and clinical findings in patients with systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 803-9.","journal-title":"Ann Rheum Dis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/art.1780330310","article-title":"Soluble interleukin-2 receptors in patients with systemic sclerosis","volume":"33","author":"Degiannis, D.; R, Seibold J.; Raskova, J.; Raska, K.; Czarnecki, M.","year":"1990","unstructured":"Degiannis D, Seibold J R, Raskova J, Raska K, Czarnecki M. Soluble interleukin-2 receptors in patients with systemic sclerosis. Arthritis Rheum 1990; 33: 375-80.","journal-title":"Arthritis Rheum"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan, A.; B, Peter J.","year":"1975","unstructured":"Bohan A, Peter J B. Polymyositis and dermatomyositis. New Eng1J7 Med 1975; 292: 344-7.","journal-title":"New Eng1J7 Med"},{"key":"ref_9","first-page":"373","article-title":"Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups. Clin Exp Immunol","volume":"81","author":"W, Miller F.; A, Love L.; A, Barbieri S.; E, Balow J.; H, Plotz P.","year":"1990","unstructured":"Miller F W, Love L A, Barbieri S A, Balow J E, Plotz P H. Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups. Clin Exp Immunol 1990; 81: 373-9."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724036331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724036331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.51.6.781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:16:27Z","timestamp":1738304187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724036331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,6]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1992,6]]}},"alternative-id":["S0003496724036331"],"URL":"https:\/\/doi.org\/10.1136\/ard.51.6.781","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1992,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble interleukin 2 receptors in patients with polymyositis\/dermatomyositis.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.51.6.781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1992 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}